ADAM10 and colorectal carcinoma: Among them, three targets, ADAM10, CD59 and TSPAN9, with AUC values of 0.83, 0.95 and 0.87, respectively, showed high-level ability to distinguish CRC patients and were selected for further analysis (Table 2 and Figure 5A).